Symbol="IDYA"
AssetType="Common Stock"
Name="Ideaya Biosciences Inc"
Description="IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality, is focused on the discovery and development of targeted therapies for selected patient populations using molecular diagnostics. The company is headquartered in South San Francisco, California."
CIK="1676725"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="7000 SHORELINE COURT, SUITE 350, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1238614000"
EBITDA="-72336000"
PERatio="None"
PEGRatio="None"
BookValue="6.9"
DividendPerShare="0"
DividendYield="0"
EPS="-1.5"
RevenuePerShareTTM="1.081"
ProfitMargin="-1.439"
OperatingMarginTTM="-1.571"
ReturnOnAssetsTTM="-0.129"
ReturnOnEquityTTM="-0.219"
RevenueTTM="47452000"
GrossProfitTTM="-38605000"
DilutedEPSTTM="-1.5"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.306"
AnalystTargetPrice="33"
TrailingPE="-"
ForwardPE="4.649"
PriceToSalesRatioTTM="16.29"
PriceToBookRatio="2.213"
EVToRevenue="8.7"
EVToEBITDA="-8.28"
Beta="0.813"
num_52WeekHigh="26.35"
num_52WeekLow="9"
num_50DayMovingAverage="23.16"
num_200DayMovingAverage="18.34"
SharesOutstanding="57290000"
DividendDate="None"
ExDividendDate="None"
symbol="IDYA"
open="21.65"
high="21.85"
low="21.19"
price="21.74"
volume="338790.00"
latest_trading_day="2023-07-24"
previous_close="21.62"
change="0.12"
change_percent="0.5550%"
aroon_positive_momentum_days="63"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="63"
Volume_recent_avg="617747"
Change_recent_avg="-0.02"
Delta_recent_avg="0.92"
Variance_recent_avg="0.46"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="63"
Aroon_momentum_negative="37"
image_negative_thumbnail_id_1="158"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0018.jpeg"
image_negative_thumbnail_id_2="143"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0033.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="995"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0157.jpeg"
image_positive_thumbnail_id_2="651"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0057.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
